Australia markets closed

Rocket Pharmaceuticals, Inc. (RCKT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
21.86-1.00 (-4.37%)
At close: 04:00PM EDT
22.31 +0.45 (+2.06%)
After hours: 06:16PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.98B
Enterprise value 1.68B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.49
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.07
52-week change 3-3.23%
S&P500 52-week change 323.76%
52-week high 332.53
52-week low 314.89
50-day moving average 322.93
200-day moving average 323.98

Share statistics

Avg vol (3-month) 3635.82k
Avg vol (10-day) 3644.44k
Shares outstanding 590.78M
Implied shares outstanding 695.02M
Float 870.67M
% held by insiders 13.44%
% held by institutions 1106.20%
Shares short (15 May 2024) 49.99M
Short ratio (15 May 2024) 415.63
Short % of float (15 May 2024) 423.43%
Short % of shares outstanding (15 May 2024) 411.01%
Shares short (prior month 15 Apr 2024) 411M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 305 Jan 2018
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 305 Jan 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-32.64%
Return on equity (ttm)-55.38%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -257.16M
Net income avi to common (ttm)-249.31M
Diluted EPS (ttm)-2.85
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)330.31M
Total cash per share (mrq)3.64
Total debt (mrq)25.95M
Total debt/equity (mrq)5.88%
Current ratio (mrq)10.47
Book value per share (mrq)4.87

Cash flow statement

Operating cash flow (ttm)-194.21M
Levered free cash flow (ttm)-140.15M